These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10977920)

  • 1. Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration.
    Boiko SS; Ostrovskaya RU; Zherdev VP; Korotkov SA; Gudasheva TA; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2000 Apr; 129(4):359-61. PubMed ID: 10977920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites].
    Boĭko SS; Zherdev VP; Dvorianinov AA; Gudasheva TA; Ostrovskaia RU; Voronina TA; Rozantsev GG; Seredenin SB
    Eksp Klin Farmakol; 1997; 60(2):53-5. PubMed ID: 9206571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interspecies differences of noopept pharmacokinetics].
    Boĭko SS; Korotkov SA; Zherdev VP; Gudasheva TA; Ostrovskaia RU; Voronina TA
    Eksp Klin Farmakol; 2004; 67(1):40-3. PubMed ID: 15079908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration.
    Ostrovskaya RU; Mirsoev TK; Romanova GA; Gudasheva TA; Kravchenko EV; Trofimov CC; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2001 Oct; 132(4):959-62. PubMed ID: 11782792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of drugs for Alzheimer's disease.
    Parnetti L
    Clin Pharmacokinet; 1995 Aug; 29(2):110-29. PubMed ID: 7586900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of aniracetam and its metabolites in rat brain.
    Ogiso T; Uchiyama K; Suzuki H; Yoshimoro M; Tanino T; Iwakai M; Uno S
    Biol Pharm Bull; 2000 Apr; 23(4):482-6. PubMed ID: 10784432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategy for the development of dipeptide drugs].
    Gudasheva TA
    Vestn Ross Akad Med Nauk; 2011; (7):8-16. PubMed ID: 21899085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of non-NMDA glutamate receptors in the EEG effects of chronic administration of noopept GVS-111 in awake rats].
    Kovalev GI; Vorob'ev VV
    Eksp Klin Farmakol; 2002; 65(6):6-9. PubMed ID: 12596524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic properties of an innovative nootropic agent based on a derivative of 3,7-diazabicyclo[3.3.1]nonane].
    Brkich GE; Pyatigorskaya NV; Beregovykh VV; Nedorubov AA; Filippova OV; Zyryanov OA
    Biomed Khim; 2020 Jan; 66(1):71-76. PubMed ID: 32116228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of the nootropic drugs].
    Boĭko SS; Vitskova GIu; Zherdev VP
    Eksp Klin Farmakol; 1997; 60(6):62-70. PubMed ID: 9460604
    [No Abstract]   [Full Text] [Related]  

  • 11. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine.
    Gudasheva TA; Boyko SS; Ostrovskaya RU; Voronina TA; Akparov VK; Trofimov SS; Rozantsev GG; Skoldinov AP; Zherdev VP; Seredenin SB
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):245-52. PubMed ID: 9358206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of hopantenic acid upon peroral administration].
    Karlina MV; Pozharitskaia ON; Kosman VM; Shikov AN; Lazukina MA; D'iachuk GI
    Eksp Klin Farmakol; 2010 Aug; 73(8):46-8. PubMed ID: 20919560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dipeptide nootropic agent GVS-111 prevents accumulation of the lipid peroxidation products during immobilization].
    Lysenko AV; Uskova NI; Ostrovskaia RU; Gudasheva TA; Voronina TA
    Eksp Klin Farmakol; 1997; 60(5):15-8. PubMed ID: 9483398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiamnesic effect of acyl-prolyl-containing dipeptide (GVS-111) in compression-induced damage to frontal cortex.
    Romanova GA; Mirzoev TK; Barskov IV; Victorov IV; Gudasheva TA; Ostrovskaya RU
    Bull Exp Biol Med; 2000 Sep; 130(9):846-8. PubMed ID: 11177261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of the new nootropic dipeptide GVS-111 in different functional disorders of the escape reaction].
    Inozemtsev AN; Trofimov SS; Borlikova GG; Firova FA; Pragina LL; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Voronina TA
    Eksp Klin Farmakol; 1998; 61(3):10-2. PubMed ID: 9690067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of permeability of derivatives of gamma-aminobutyric and gamma-hydroxybutyric acids through hemato-encephalic barrier].
    Nasybullina NM; Zherdev VP; Gunar VI; Kopelevich VM; Kozlova GS
    Eksp Klin Farmakol; 1997; 60(6):52-4. PubMed ID: 9460601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-assisted laser desorption/ionization imaging mass spectrometry of intraperitoneally injected danegaptide (ZP1609) for treatment of stroke-reperfusion injury in mice.
    Wang JSH; Freitas-Andrade M; Bechberger JF; Naus CC; Yeung KK; Whitehead SN
    Rapid Commun Mass Spectrom; 2018 Jun; 32(12):951-958. PubMed ID: 29575411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress.
    Andreeva NA; Stel'mashuk EV; Isaev NK; Ostrovskaya RU; Gudasheva TA; Viktorov IV
    Bull Exp Biol Med; 2000 Oct; 130(10):969-72. PubMed ID: 11177296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nootropics: pharmacological properties and therapeutic use.
    Gabryel B; Trzeciak HI
    Pol J Pharmacol; 1994; 46(5):383-94. PubMed ID: 7894524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites].
    Boĭko SS; Zherdev VP; Gudasheva TA; Vasilevich NI; Ostrovskaia RU; Voronina TA; Rozantsev GG
    Eksp Klin Farmakol; 1996; 59(2):38-40. PubMed ID: 8974563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.